Disclosed positions

Estimated from their latest filings — positions may have changed since

$545.3K

combined est. value

Stock	Shares	Price	Value	Weight	As of
GDTCCytoMed Therapeutics Ltd	630,324	$0.8651	$545.3K	100%	2026-07-20

GDTC

CytoMed Therapeutics Ltd

$545.3K

630,324 sh

Activity

Open-market buy & sell volume

BuySell

Total +$428.8K bought

Most bought

GDTC

$428.8K

All filings on record

Every Form 4 transaction we track for this filer

all 3buys 3sells 0

Stock	Transaction	Date	~6mo later
GDTCCytoMed Therapeutics Ltd	Buy $150.0K · 100,000 sh	2026-07-20	in progress
GDTCCytoMed Therapeutics Ltd	Buy $150.0K · 100,000 sh	2026-07-14	in progress
GDTCCytoMed Therapeutics Ltd	Buy $128.8K · 112,000 sh	2026-05-13	in progress

GDTCBuy

2026-07-20 · CytoMed Therapeutics Ltd

$150.0K

in progress

GDTCBuy

2026-07-14 · CytoMed Therapeutics Ltd

$150.0K

in progress

GDTCBuy

2026-05-13 · CytoMed Therapeutics Ltd

$128.8K

in progress

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.